MA41048A - Utilité d'une protéine dans la prédiction d'effets in vivo - Google Patents

Utilité d'une protéine dans la prédiction d'effets in vivo

Info

Publication number
MA41048A
MA41048A MA041048A MA41048A MA41048A MA 41048 A MA41048 A MA 41048A MA 041048 A MA041048 A MA 041048A MA 41048 A MA41048 A MA 41048A MA 41048 A MA41048 A MA 41048A
Authority
MA
Morocco
Prior art keywords
predicting
usefulness
protein
vivo effects
vivo
Prior art date
Application number
MA041048A
Other languages
English (en)
Inventor
Christopher B Black
Kenneth R Brouwer
Jonathan P Jackson
Original Assignee
Qualyst Transp Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qualyst Transp Solutions Llc filed Critical Qualyst Transp Solutions Llc
Publication of MA41048A publication Critical patent/MA41048A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MA041048A 2014-10-07 2015-10-06 Utilité d'une protéine dans la prédiction d'effets in vivo MA41048A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462060916P 2014-10-07 2014-10-07

Publications (1)

Publication Number Publication Date
MA41048A true MA41048A (fr) 2017-08-15

Family

ID=55653702

Family Applications (1)

Application Number Title Priority Date Filing Date
MA041048A MA41048A (fr) 2014-10-07 2015-10-06 Utilité d'une protéine dans la prédiction d'effets in vivo

Country Status (11)

Country Link
US (1) US20170205393A1 (fr)
EP (2) EP4509835A3 (fr)
JP (5) JP7097697B2 (fr)
CN (4) CN119932147A (fr)
AU (3) AU2015328138A1 (fr)
CA (1) CA2962491C (fr)
DK (1) DK3204767T3 (fr)
FI (1) FI3204767T3 (fr)
IL (1) IL251605B (fr)
MA (1) MA41048A (fr)
WO (1) WO2016057626A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE059760T2 (hu) * 2016-09-16 2022-12-28 Qualyst Transp Solutions Llc Módszerek és rendszerek a potenciálisan szisztémás vagy májtoxicitást okozó vegyületek szûrésére
CN116529390A (zh) * 2020-11-25 2023-08-01 Jsr株式会社 评价被验物质通过人肝细胞样细胞而排出的方法
JP7472320B2 (ja) * 2020-12-18 2024-04-22 中外製薬株式会社 動的解析による相対ｆｕ比の測定方法
AU2023311981A1 (en) * 2022-07-20 2025-02-20 Symbiocell Tech, Llc Species-specific tissue culture medium for the propagation of cells
JP2025158141A (ja) * 2025-07-25 2025-10-16 株式会社大都技研 遊技台
JP2025158149A (ja) * 2025-07-25 2025-10-16 株式会社大都技研 遊技台

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US411077A (en) * 1889-09-17 Hugh garment turley
US4110077A (en) 1976-10-08 1978-08-29 Hoffmann-La Roche Inc. Determination of β-lipoproteins in blood serum with polyanethole sulfonate
EP2293063A1 (fr) * 1999-03-17 2011-03-09 University Of North Carolina At Chapel Hill Procédé de criblage de composés candidats pour la sensibilité à la sécretion biliaire
US7601494B2 (en) 1999-03-17 2009-10-13 The University Of North Carolina At Chapel Hill Method of screening candidate compounds for susceptibility to biliary excretion
US6458589B1 (en) * 2000-04-27 2002-10-01 Geron Corporation Hepatocyte lineage cells derived from pluripotent stem cells
JP4913030B2 (ja) * 2005-01-31 2012-04-11 株式会社バイオセレンタック 経皮吸収製剤、経皮吸収製剤保持シート、及び経皮吸収製剤保持用具
WO2007146203A1 (fr) 2006-06-08 2007-12-21 The University Of North Carolina At Chapel Hill Impulsions de compartiments biliaires dans des hépatocytes cultivés en sandwich
EP2561353A4 (fr) * 2010-04-19 2013-08-28 Univ North Carolina Prédicteurs de disposition pharmacocinétique et pharmacodynamique d'agents médiés par véhicule

Also Published As

Publication number Publication date
AU2024204363A1 (en) 2024-07-11
FI3204767T3 (fi) 2025-11-28
IL251605B (en) 2022-01-01
EP3204767A4 (fr) 2018-02-28
JP7097697B2 (ja) 2022-07-08
AU2015328138A1 (en) 2017-04-27
EP3204767B1 (fr) 2025-09-10
EP4509835A2 (fr) 2025-02-19
JP2025124643A (ja) 2025-08-26
EP4509835A3 (fr) 2025-05-28
CN107003299A (zh) 2017-08-01
JP2023098948A (ja) 2023-07-11
JP2020182475A (ja) 2020-11-12
AU2021269341A1 (en) 2021-12-09
US20170205393A1 (en) 2017-07-20
CA2962491C (fr) 2023-03-21
CN119753076A (zh) 2025-04-04
JP2025160199A (ja) 2025-10-22
CN119932147A (zh) 2025-05-06
CA2962491A1 (fr) 2016-04-14
JP2017532066A (ja) 2017-11-02
WO2016057626A1 (fr) 2016-04-14
EP3204767A1 (fr) 2017-08-16
CN119932146A (zh) 2025-05-06
DK3204767T3 (da) 2025-11-24
IL251605A0 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
IL283965A (en) Antibodies against cd73 and uses thereof
EP3556773A4 (fr) Anticorps anti-cd73 humain
IL254516B (en) Proteins specific for cd137
EP3411494A4 (fr) Séquençage super-résolution
DK3250703T3 (da) Ligeringsanalyser i væskefase
EP3374143A4 (fr) Lentille d'accommodation dotée d'une cavité
IL244748B (en) Methods and processes for non-invasive assessment of genetic variations
EP3744362C0 (fr) Pompe sanguine
DE112015002825A5 (de) Nicht-invasive Stoffanalyse
EP3320395C0 (fr) Affichages composites électrophorétiques
EP3385181A4 (fr) Récipient séparable à stratification
DK3107562T3 (da) P97-ids-fusionsproteiner
EP3538141A4 (fr) Ligand ilt3
FR3020700B1 (fr) Methode pour la quantification de la presence de graisses dans une region du cœur
EP3191581C0 (fr) Mutagenèse ciblée dans la spiruline
HUE064240T2 (hu) Fehérjetisztítás
MA41048A (fr) Utilité d'une protéine dans la prédiction d'effets in vivo
DK3702450T3 (da) Protein
EP3458307A4 (fr) Stabilisateur de charge de fluide
DK3206535T3 (da) Ligevægtsledforbindelse
HRP20182029T1 (hr) Uti-fuzijski proteini
DK3271724T3 (da) Anvendelse af en standard til påvisning af proteinaggregater i en proteinfejlfoldningssygdom
EP3341720A4 (fr) Méthodes permettant d'améliorer la prise en charge du diabète
DK3099793T3 (da) Protein
FR3020033B1 (fr) Ensemble pour cycle